Centogene NV
(NASDAQ : CNTG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. -7.31%231.337.5%$638.81m
EFXEquifax, Inc. -2.93%282.472.0%$192.71m
CHGGChegg, Inc. -1.31%28.5713.1%$186.04m
FLTFLEETCOR Technologies, Inc. 0.09%208.063.7%$147.05m
CRLCharles River Laboratories International, Inc. -2.32%357.474.5%$142.89m
CPRTCopart, Inc. -0.95%145.624.4%$137.69m
ADGIAdagio Therapeutics, Inc. -1.42%45.830.0%$128.26m
CLVTClarivate Plc -6.74%23.520.0%$106.78m
PSFEPaysafe Ltd. -6.77%3.380.0%$102.21m
FOURShift4 Payments, Inc. -2.84%51.000.0%$95.59m
TALTAL Education Group -8.98%4.560.7%$89.42m
BKKTBakkt Holdings, Inc. -6.66%13.030.0%$88.61m
MRVIMaravai Lifesciences Holdings, Inc. -2.05%42.150.0%$82.19m
PAGSPagSeguro Digital Ltd. -5.78%24.800.0%$77.20m
SYNHSyneos Health, Inc. -1.44%97.230.0%$70.18m

Company Profile

Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.